{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:54:29Z","timestamp":1775246069543,"version":"3.50.1"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007224","name":"National Foundation for Science and Technology Development","doi-asserted-by":"publisher","award":["108.05-2017.13"],"award-info":[{"award-number":["108.05-2017.13"]}],"id":[{"id":"10.13039\/100007224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007224","name":"National Foundation for Science and Technology Development","doi-asserted-by":"publisher","award":["108.05-2017.13"],"award-info":[{"award-number":["108.05-2017.13"]}],"id":[{"id":"10.13039\/100007224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/90673\/2012"],"award-info":[{"award-number":["SFRH\/BPD\/90673\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0192176","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T13:38:13Z","timestamp":1518097093000},"page":"e0192176","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["A desirability-based multi objective approach for the virtual screening discovery of broad-spectrum anti-gastric cancer agents"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3710-0035","authenticated-orcid":true,"given":"Yunierkis","family":"Perez-Castillo","sequence":"first","affiliation":[]},{"given":"Aminael","family":"S\u00e1nchez-Rodr\u00edguez","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Tejera","sequence":"additional","affiliation":[]},{"given":"Maykel","family":"Cruz-Monteagudo","sequence":"additional","affiliation":[]},{"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[]},{"given":"M. Nat\u00e1lia D. S.","family":"Cordeiro","sequence":"additional","affiliation":[]},{"given":"Huong","family":"Le-Thi-Thu","sequence":"additional","affiliation":[]},{"given":"Hai","family":"Pham-The","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"ref1","article-title":"Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications","author":"I Gullo","year":"2017","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S1470-2045(14)70420-6","article-title":"Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial","volume":"15","author":"H Wilke","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION","volume":"64","author":"P Lauren","year":"1965","journal-title":"Acta Pathol Microbiol Scand"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0344-0338(11)80878-2","article-title":"New elements for an updated classification of the carcinomas of the stomach","volume":"191","author":"F Carneiro","year":"1995","journal-title":"Pathol Res Pract"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.gastro.2013.05.010","article-title":"Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil","volume":"145","author":"Z Lei","year":"2013","journal-title":"Gastroenterology"},{"key":"ref6","first-page":"4","article-title":"Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets","author":"S Vasaikar","year":"2016","journal-title":"Biomedicines"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.drudis.2017.02.004","article-title":"Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery","volume":"22","author":"M Cruz-Monteagudo","year":"2017","journal-title":"Drug Discov Today"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11095-010-0065-2","article-title":"In-silico approaches to multi-target drug discovery: computer aided multi-target drug design, multi-target virtual screening","volume":"27","author":"XH Ma","year":"2010","journal-title":"Pharm Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrg1272","article-title":"Network biology: understanding the cell\u2019s functional organization","volume":"5","author":"A-L Barab\u00e1si","year":"2004","journal-title":"Nat Rev Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1517\/17460441.2.6.799","article-title":"How to design multi-target drugs","volume":"2","author":"T Korcsm\u00e1ros","year":"2007","journal-title":"Expert Opin Drug Discov"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1574362409666140206221931","article-title":"Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops","volume":"8","author":"V von Manstein","year":"2013","journal-title":"Curr Signal Transduct Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejmech.2014.01.060","article-title":"Multifunctional compounds: smart molecules for multifactorial diseases","volume":"76","author":"Y Bansal","year":"2014","journal-title":"Eur J Med Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1471-2105-13-186","article-title":"Integrated QSAR study for inhibitors of Hedgehog Signal Pathway against multiple cell lines:a collaborative filtering method","volume":"13","author":"J Gao","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"ref14","article-title":"From flamingo dance to (desirable) drug discovery: a nature-inspired approach","author":"A S\u00e1nchez-Rodr\u00edguez","year":"2017","journal-title":"Drug Discov Today"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/jcc.20994","article-title":"Desirability-based multiobjective optimization for global QSAR studies: application to the design of novel NSAIDs with improved analgesic, antiinflammatory, and ulcerogenic profiles","volume":"29","author":"M Cruz-Monteagudo","year":"2008","journal-title":"J Comput Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2174\/138955712802762329","article-title":"Desirability-based multi-objective QSAR in drug discovery","volume":"12","author":"M Cruz-Monteagudo","year":"2012","journal-title":"Mini Rev Med Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/minf.200900047","article-title":"Prioritizing Hits with Appropriate Trade-Offs Between HIV-1 Reverse Transcriptase Inhibitory Efficacy and MT4 Blood Cells Toxicity Through Desirability-Based Multiobjective Optimization and Ranking","volume":"29","author":"M Cruz-Monteagudo","year":"2010","journal-title":"Mol Inform"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e36948","DOI":"10.1371\/journal.pone.0036948","article-title":"Molecular Evolution of a Peptide GPCR Ligand Driven by Artificial Neural Networks","volume":"7","author":"S Bandholtz","year":"2012","journal-title":"PLOS ONE"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e0118324","DOI":"10.1371\/journal.pone.0118324","article-title":"Global Analysis Reveals Families of Chemical Motifs Enriched for hERG Inhibitors","volume":"10","author":"F Du","year":"2015","journal-title":"PLOS ONE"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e0155419","DOI":"10.1371\/journal.pone.0155419","article-title":"Integrated Computational Solution for Predicting Skin Sensitization Potential of Molecules","volume":"11","author":"KLS Kumar","year":"2016","journal-title":"PLOS ONE"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13062-015-0046-9","article-title":"QSAR based model for discriminating EGFR inhibitors and non-inhibitors using Random forest","volume":"10","author":"H Singh","year":"2015","journal-title":"Biol Direct"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e0144426","DOI":"10.1371\/journal.pone.0144426","article-title":"Mining Chemical Activity Status from High-Throughput Screening Assays","volume":"10","author":"O Soufan","year":"2015","journal-title":"PLOS ONE"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.2174\/1381612822666160302103542","article-title":"Ligand-Based Virtual Screening Using Tailored Ensembles: A Prioritization Tool for Dual A2AAdenosine Receptor Antagonists \/ Monoamine Oxidase B Inhibitors","volume":"22","author":"AM Helguera","year":"2016","journal-title":"Curr Pharm Des"},{"key":"ref24","first-page":"2773","article-title":"Characteristics of cell lines established from human gastric carcinoma","volume":"50","author":"JG Park","year":"1990","journal-title":"Cancer Res"},{"key":"ref25","first-page":"1703","article-title":"Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach","volume":"43","author":"SC Barranco","year":"1983","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"A Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"ref27","unstructured":"The MathWorks Inc. MATLAB. 2015."},{"key":"ref28","unstructured":"ChemAxon. JChem for Excel [Internet]. 2017. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chemaxon.com\" xlink:type=\"simple\">http:\/\/www.chemaxon.com<\/ext-link>"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/ci100176x","article-title":"Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research","volume":"50","author":"D Fourches","year":"2010","journal-title":"J Chem Inf Model"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1021\/acs.jcim.6b00129","article-title":"Trust, but Verify II: A Practical Guide to Chemogenomics Data Curation","volume":"56","author":"D Fourches","year":"2016","journal-title":"J Chem Inf Model"},{"key":"ref31","article-title":"Chemaxon Standardizer","year":"2017","journal-title":"Chemaxon Standardizer"},{"key":"ref32","article-title":"ISIDA\u2014Platform for Virtual Screening Based on Fragment and Pharmacophoric Descriptors","author":"A Varnek","year":"2008","journal-title":"Current Computer-Aided Drug Design"},{"key":"ref33","article-title":"JChem","year":"2017","journal-title":"JChem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","article-title":"Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking","volume":"55","author":"MM Mysinger","year":"2012","journal-title":"J Med Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10822-005-9008-0","article-title":"Substructural fragments: an universal language to encode reactions, molecular and supramolecular structures","volume":"19","author":"A Varnek","year":"2005","journal-title":"J Comput Aided Mol Des"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1109\/TPAMI.2005.159","article-title":"Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy","volume":"27","author":"H Peng","year":"2005","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1142\/5089","article-title":"Least Squares Support Vector Machines","author":"JAK Suykens","year":"2002"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/026119290503300508","article-title":"QSAR applicabilty domain estimation by projection of the training set descriptor space: a review","volume":"33","author":"J Jaworska","year":"2005","journal-title":"Altern Lab Anim ATLA"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1109\/MCAS.2006.1688199","article-title":"Ensemble based systems in decision making","volume":"6","author":"R Polikar","year":"2006","journal-title":"IEEE Circuits Syst Mag"},{"key":"ref40","first-page":"199","article-title":"Selected Papers of Hirotugu Akaike","author":"H Akaike","year":"1998"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/ci600426e","article-title":"Evaluating virtual screening methods: good and bad metrics for the \u201cearly recognition\u201d problem","volume":"47","author":"J-F Truchon","year":"2007","journal-title":"J Chem Inf Model"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10822-007-9163-6","article-title":"Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection\u2014what can we learn from earlier mistakes?","volume":"22","author":"J Kirchmair","year":"2008","journal-title":"J Comput Aided Mol Des"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1021\/ci0100144","article-title":"Protocols for bridging the peptide to nonpeptide gap in topological similarity searches","volume":"41","author":"RP Sheridan","year":"2001","journal-title":"J Chem Inf Comput Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1021\/ci300146h","article-title":"GA(M)E-QSAR: a novel, fully automatic genetic-algorithm-(meta)-ensembles approach for binary classification in ligand-based drug design","volume":"52","author":"Y P\u00e9rez-Castillo","year":"2012","journal-title":"J Chem Inf Model"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11030-014-9513-y","article-title":"Toward the computer-aided discovery of FabH inhibitors. Do predictive QSAR models ensure high quality virtual screening performance?","volume":"18","author":"Y P\u00e9rez-Castillo","year":"2014","journal-title":"Mol Divers"},{"key":"ref46","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","author":"DS Wishart","year":"2017","journal-title":"Nucleic Acids Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0192176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T12:54:46Z","timestamp":1570712086000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0192176"}},"subtitle":[],"editor":[{"given":"Giovanni","family":"Maga","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0192176","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]}}}